SCHEMBL3986385

SCHEMBL3986385

O=C(O)Oc1ccc(-c2ccc(Br)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.50
LDHA P00338 1/20 0.48
MAPK1 P28482 2/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
ALDH1A1 P00352 1/20 0.46
MCL1 Q07820 4/20 0.43
ALAD P13716 1/20 0.43
HAO1 Q9UJM8 1/20 0.43
GAA P10253 1/20 0.42
SRD5A2 P31213 1/20 0.42
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
TP53 P04637 2/20 0.40
CFD P00746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504737 0.93 LDHA (0.54) HSD17B10LDHAMAPK1LMNAMEN1
SCHEMBL2637327 0.89 HSD17B10 (0.59) HSD17B10LMNAMEN1MAPTRAB9A
SCHEMBL194962 0.89 HSD17B10 (0.59) HSD17B10LMNAMEN1MAPTRAB9A
SCHEMBL177352 0.85 HSD17B10 (0.63) HSD17B10MAPK1LMNAMEN1MAPT
SCHEMBL1638842 0.84 MEN1 (0.45) HSD17B10LDHAMAPK1LMNAMEN1
SCHEMBL2760661 0.82 KMT2A (0.55) HSD17B10LMNAMEN1MAPTRAB9A
SCHEMBL17714039 0.82 KMT2A (0.55) HSD17B10LMNAMEN1MAPTRAB9A
SCHEMBL10439489 0.82 KMT2A (0.51) LDHAMAPK1LMNAMEN1MAPT
SCHEMBL465132 0.81 LMNA (0.52) HSD17B10LMNAMEN1MAPTRAB9A
Biphenyl SCHEMBL6667027 0.80 KMT2A (0.53) HSD17B10LMNAMEN1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534689-A1 NOVEL CARBOXAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-06-01 EP claimed
WO-2004024702-A1 NOVEL CARBOXAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-03-25 WO claimed
US-7585983-B2 Alkylenedioxythiophenes and poly(alkylenedioxythiophenes) containing mesogenic groups H.C. STARCK, GMBH (DE) 2009-09-08 US disclosed
EP-2061767-A1 ARYLAMINOARYL-ALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, PROCESSES FOR PREPARING THEM, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THEIR USE Sanofi-Aventis (FR) 2009-05-27 EP disclosed
WO-2008017381-A1 ARYLAMINOARYL-ALKYL-SUBSTITUTED IMIDAZOLIDINE-2,4-DIONES, PROCESSES FOR PREPARING THEM, MEDICAMENTS COMPRISING THESE COMPOUNDS, AND THEIR USE SANOFI-AVENTIS (FR) 2008-02-14 WO disclosed
EP-1534689-A1 NOVEL CARBOXAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-06-01 EP disclosed
US-20040227128-A1 Alkylenedioxythiophenes and poly(alkylenedioxythiophenes) containing mesogenic groups H.C. STARCK GMBH (DE) 2004-11-18 US disclosed
WO-2004024702-A1 NOVEL CARBOXAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-03-25 WO disclosed
EP-0496378-B1 Biphenylderivatives, drugs containing these compounds and processes for their preparation THOMAE GMBH DR K (DE) 1995-09-20 EP disclosed
EP-0574808-A1 Amidine-biphenyl derivatives, process for their production & medical preparation containing them Dr. Karl Thomae GmbH (DE) 1993-12-22 EP disclosed
EP-0496378-A1 Biphenylderivatives, drugs containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1992-07-29 EP disclosed